• Aucun résultat trouvé

<< Back to Publications >> Go to Table of Contents

N/A
N/A
Protected

Academic year: 2022

Partager "<< Back to Publications >> Go to Table of Contents"

Copied!
68
0
0

Texte intégral

(1)
(2)
(3)

<< Back to Publications >> Go to Table of Contents

(4)

CONTENTS

Foreword vii

1. Introduction 1

Background 1

Research on acupuncture 1

Need for guidelines for the clinical

evaluation of acupuncture 2

2. Glossary 3

Terms relating to evaluation methodology 3 Terms relating specifically to acupuncture

Studies 3

3. Goals and objectives of the guidelines 5

Goals 5

Objectives 5

4. General considerations 6

Legal considerations 6

Ethical considerations 6

Considering the character of acupuncture 6

Clinical research 7

Laboratory studies 8

Animal research 8

Education 8

5. Research methodology 9

Literature review 9

Terminology and technology 9

Investigators 10

Clinical research design and

rational use of acupuncture 11 Randomized controlled clinical

trial design 13

(5)

Protocol development 16

Research knowledge 18

Case report forms 23

Data management 23

Ethics review board 24

Statistical analysis 24

Monitoring of studies 25

Reporting 26

Implementation 26

Conclusions 27

6. Using the guidelines 28

Annexes

Annex 1 Strategic approaches to randomized

controlled clinical trials 31

Annex 2 World Medical Association Declaration 35 of Helsinki

Annex 3 Report of the working group on Clinical Research Methodology for Acupuncture, Aomori, Japan,

1-4 June 1994 41

Annex 4 List of members, observers and secretariat of the working group on Clinical Research Methodology for Acupuncture, Aomori, Japan,

1-4 June 1994 57

Bibliography 61

<< Back to Publications >> Go to Table of Contents

(6)
(7)

<< Back to Table of Contents

(8)
(9)

<< Back to Table of Contents

(10)
(11)

<< Back to Table of Contents

(12)

<< Back to Table of Contents

(13)
(14)
(15)

<< Back to Table of Contents

(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)

<< Back to Table of Contents

(35)

<< Back to Table of Conte nts

(36)
(37)
(38)
(39)

<< Back to Table of Contents

(40)
(41)
(42)
(43)
(44)

<< Back to Table of Contents

(45)
(46)
(47)
(48)
(49)
(50)
(51)
(52)
(53)
(54)
(55)
(56)
(57)
(58)
(59)
(60)

<< Back to Table of Conte nts

(61)
(62)
(63)
(64)

<< Back to Table of Contents

(65)
(66)

<< Back to Table of Conte nts

(67)
(68)

Références

Documents relatifs

Domaine Bonneau du Martray Corton-Charlemagne Grand Cru ‘98 500 Domaine Bonneau du Martray Corton-Charlemagne Grand Cru ‘04 450 Domaine Bonneau du Martray Corton-Charlemagne

Por favor, seleccione los marcos azul para acceder al

The overall objective has been to strengthen the pharmaceutical sector in order to ensure that all inhabitants in Ghana have access to essential drugs that are safe, effective,

WHO Regional Director of the Western Pacific Region working Group on Herbal Medicines, 8 December 1997..

Short-answer exercise Suggested field experience for assessment of practical skills.. Guidelines: senses and development of a plan of

The Committee at its eighth session in 2013 called upon States Parties and the General Assembly, as well as the Secretariat, category 2 centres, non-governmental organizations and

15. Elements inscribed on the List of Intangible Cultural Heritage in Need of Urgent Safeguarding and the Representative List of the Intangible Cultural Heritage of Humanity, as

The Committee at its eighth session in 2013 called upon States Parties and the General Assembly, as well as the Secretariat, category 2 centres, non-governmental organizations and